Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Health symbols : Opk save search
OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results
Published: 2024-02-27 (Crawled : 21:00) - globenewswire.com
NXPL | $1.25 -4.94% 140K
|
Manufacturing
|
| O: 5.84%
H: 2.25%
C: -5.19%
OPK | $1.225 -0.41% 1.1M
|
Health Technology
|
| O: -4.76%
H: 1.0%
C: -1.45%
business health financial results
OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024
Published: 2024-02-22 (Crawled : 21:00) - globenewswire.com
OPK | $1.225 -0.41% 1.1M
|
Health Technology
|
| O: 2.74%
H: 0.33%
C: -5.09%
report health financial results
OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser’s Option to Purchase Additional Notes
Published: 2024-01-09 (Crawled : 21:00) - globenewswire.com
OPK | $1.225 -0.41% 1.1M
|
Health Technology
|
| O: 1.92%
H: 2.83%
C: -4.72%
health million offering
OPKO Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-08 (Crawled : 13:00) - globenewswire.com
OPK | $1.225 -0.41% 1.1M
|
Health Technology
|
| O: 4.66%
H: 10.75%
C: 7.53%
conference health
OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029
Published: 2024-01-05 (Crawled : 05:00) - globenewswire.com
OPK | $1.225 -0.41% 1.1M
|
Health Technology
|
| O: 0.99%
H: 3.61%
C: -2.96%
health million offering
OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029
Published: 2024-01-03 (Crawled : 22:00) - globenewswire.com
OPK | $1.225 -0.41% 1.1M
|
Health Technology
|
| O: -18.67%
H: 0.0%
C: -25.68%
health offering
OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023
Published: 2023-10-31 (Crawled : 12:00) - globenewswire.com
OPK | $1.225 -0.41% 1.1M
|
Health Technology
|
| O: -0.81%
H: 3.28%
C: 2.46%
report health financial results
OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023
Published: 2023-10-25 (Crawled : 20:00) - globenewswire.com
OPK | $1.225 -0.41% 1.1M
|
Health Technology
|
| O: -0.79%
H: 1.59%
C: 0.0%
health kidney week
OPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023
Published: 2023-07-25 (Crawled : 20:00) - globenewswire.com
OPK | $1.225 -0.41% 1.1M
|
Health Technology
|
| O: -1.66%
H: 2.25%
C: 0.0%
report health financial results
OPKO Health to Hold Virtual R&D Day on March 20, 2023
Published: 2023-03-09 (Crawled : 13:00) - globenewswire.com
OPK | $1.225 -0.41% 1.1M
|
Health Technology
|
| O: 0.88%
H: 15.79%
C: 6.14%
day health
Whistleblower Law Collaborative LLC Wins Law360 Health Care Group of the Year
Published: 2023-03-01 (Crawled : 19:00) - prnewswire.com
OPK | $1.225 -0.41% 1.1M
|
Health Technology
|
| O: -1.71%
H: 5.22%
C: 4.35%
care health year group
OPKO Health Reports Fourth Quarter 2022 Business Highlights and Financial Results
Published: 2023-02-23 (Crawled : 21:00) - globenewswire.com
OPK | $1.225 -0.41% 1.1M
|
Health Technology
|
| O: -3.57%
H: 0.0%
C: -1.85%
health financial results
OPKO Health to Report Fourth Quarter 2022 Financial Results on February 23, 2023
Published: 2023-02-16 (Crawled : 17:00) - globenewswire.com
OPK | $1.225 -0.41% 1.1M
|
Health Technology
|
| O: -0.83%
H: 1.67%
C: -0.83%
report health financial results
OPKO Health Announces Leadership Changes for BioReference Laboratories
Published: 2022-08-16 (Crawled : 21:00) - globenewswire.com
OPK | $1.225 -0.41% 1.1M
|
Health Technology
|
| O: -2.32%
H: 1.58%
C: 0.4%
health
OPKO Health Acquires ModeX Therapeutics, Gains Proprietary Immunotherapy Technology with a Focus on Oncology and Infectious Diseases
Published: 2022-05-09 (Crawled : 14:00) - biospace.com/
DHR | $235.02 -0.57% 750K
|
Health Technology
|
| O: -1.74%
H: 0.98%
C: -2.24%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.84%
H: 0.0%
C: 0.0%
OPK | $1.225 -0.41% 1.1M
|
Health Technology
|
| O: -2.67%
H: 7.06%
C: -4.31%
immunotherapy health technology disease
OPKO Health to Report Fourth Quarter 2021 Financial Results on February 24, 2022
Published: 2022-02-17 (Crawled : 19:00) - biospace.com/
OPK | $1.225 -0.41% 1.1M
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: -4.27%
health financial results report results
OPKO Health Announces Topline Results from Phase 2 Trial Evaluating RAYALDEE to Treat Symptomatic COVID-19 Outpatients
Published: 2021-12-23 (Crawled : 14:00) - biospace.com/
OPK | $1.225 -0.41% 1.1M
|
Health Technology
|
| O: 0.87%
H: 4.09%
C: 2.58%
covid-19 health phase 2 trial covid topline results results topline
OPKO Health Receives U.S. FDA Approval for the 4Kscore® Test
Published: 2021-12-08 (Crawled : 14:00) - biospace.com/
OPK | $1.225 -0.41% 1.1M
|
Health Technology
|
| O: 3.78%
H: 2.01%
C: 1.01%
4kscore fda fda approval approval test health
OPKO Health to Participate in Two Upcoming Investment Conferences
Published: 2021-08-30 (Crawled : 13:15) - globenewswire.com
OPK | $1.225 -0.41% 1.1M
|
Health Technology
|
| O: 1.73%
H: 2.09%
C: 0.26%
conference health
OPKO Health to Report Second Quarter 2021 Financial Results on July 29, 2021
Published: 2021-07-20 (Crawled : 14:00) - biospace.com/
OPK | $1.225 -0.41% 1.1M
|
Health Technology
|
| O: -1.13%
H: 3.72%
C: 3.44%
financial results results health
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
NVFY | $2.71 28.44% 31M
|
Consumer Durables
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
AULT | $0.2998 23.83% 53M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.